NEURALTECH BIOPHARMA SL
Company details
- Active NIF/CIF: B98544968
-
-
-
-
Address: Calle de la Antigua Senda de Senent, 1, 46023 Valencia, Valencia, España See in map
-
-
Featured products:
More information on NEURALTECH BIOPHARMA SL
-
MARTINEZ RAMOS CRISTINAConsejeroAppointment: 29/07/2013
-
MARTINEZ RAMOS CRISTINASecretarioAppointment: 29/07/2013
-
AGUSTI FELIU ANAConsejeroAppointment: 29/07/2013
-
AGUSTI FELIU ANAPresidenteAppointment: 29/07/2013
-
UREÑA PERALTA JUAN RAMONConsejeroAppointment: 29/07/2013
-
UREÑA PERALTA JUAN RAMONConsejero delegado solidarioAppointment: 29/07/2013
-
HERNANDEZ RABAZA VICENTEConsejeroAppointment: 29/07/2013
-
HERNANDEZ RABAZA VICENTEConsejero delegado solidarioAppointment: 29/07/2013
-
MARTINEZ GUAITA SANDRAConsejeroAppointment: 29/07/2013
-
MARTINEZ GUAITA SANDRAConsejero delegado solidarioAppointment: 29/07/2013
Other information
The CIF of NEURALTECH BIOPHARMA SL is B98544968 and its business status is active. Its economic activity belongs to the CNAE 7490 - Otras actividades profesionales, científicas y técnicas n.c.o.p.. Its SIC is 8999 - Servicios.
NEURALTECH BIOPHARMA SL has Between 10 and 49 employees employees and an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Valencia. It has a total of 10 registration charges. Its latest announcement in Borme was published on 29/07/2013 and its last deposit of ordinary annual accounts is from the year 2020.
You can check the contact details of NEURALTECH BIOPHARMA SL such as phone number, address, or website in the Company Data module.
For more information about NEURALTECH BIOPHARMA SL, you can acquire one of our available financial reports, the Annual Accounts of the company, or check its payment incidents in the RAI delinquency file.
All the financial, business, and legal information we provide about NEURALTECH BIOPHARMA SL comes from official sources and is updated daily.
Do you want to know more about NEURALTECH BIOPHARMA SL??
Find out more about this company by consulting these reports: